Prevalence of Thyroid Dysfunction and Autoimmunity among First Degree Relatives of Patients with Graves’ Disease at Aminu Kano Teaching Hospital, Kano, Nigeria.
Main Article Content
Keywords
Autoimmune Thyroid disorder, First degree relatives, Graves’ disease, North-Western Nigeria, Thyroid dysfunction.
Abstract
Background: Graves’ disease has a familial predisposition with about 15% of the patients having a close relative with the same disorder, while about 50% of the relatives of patients with Graves’ have circulating thyroid autoantibodies. This study determined and compared the prevalence of thyroid dysfunction, and autoimmunity among healthy individuals, and first-degree relatives of patients with Graves’ disease at Aminu Kano Teaching Hospital (AKTH), Kano.
Methodology: A cross-sectional descriptive study design was used to study 87 first degree relatives of patients with Graves’ disease comprising of 5.7% fathers, 3.4% mothers, 29.9% brothers, 29.9% sisters, 16.1% sons, and 14.9% daughters; as well as 87 age and gender-matched controls selected using a systematic sampling technique. A pretested interviewer-administered questionnaire was administered to the eligible study participants. Anthropometric and clinical parameters were measured, and blood samples were assessed for TSH, fT3, fT4, anti-TPO, and anti-Tg antibodies. Data was analysed using SPSS version 22 for Windows with an α value of ≤0.05.
Results: The mean ±SD age of the study subjects and controls were 29.4±9.0 years, and 31.6±8.8 years respectively. About half 45 (51.7%) of the respondents were males among the study subjects and controls respectively. Up to 12.6% of study subjects had raised thyroid stimulating hormone (TSH). Overt hypothyroidism was observed among 5.7% of study subjects and none among the controls. Anti-thyroid peroxidase (anti-TPO) antibodies were positive among 4.6% of the study subjects while 1.1% of controls had positive anti-TPO antibodies. Anti-thyroglobulin antibody (anti-Tg) positivity was found among 23.0% of study subjects, while 9.2% of controls had positive anti-Tg antibodies.
Conclusion: Primary Hypothyroidism was the predominant thyroid dysfunction found amongst the relatives of patients with Graves’ disease. The government and relevant stakeholders should develop a model that will mandate screening and follow-up amongst the first-degree relatives of patients with Graves’ disease.
References
2. Gardner DG, Shobach D, editors. The Thyroid gland. in: Greenspan's Basic and Clinical Endocrinology.10th edition, New York: McGraw Hill edu,.2018; 7:171.
3. Longo DL, Fauci AS, Loscalzo J, Kasper DL, Hauser SL, Jameson JL et al, editors. Disorders of the Thyroid Gland; In: Harrison’s principles of internal medicine. 19th edition. New York: McGraw Hill, 2015; 16:405:2283.
4. Brix TH, Kyvik KO, Christensen K, Hegedüs L. Evidence for a Major Role of Heredity in Graves’ Disease: A Population-Based Study of Two Danish Twin Cohorts. J Clin Endocrinol Metab, 2001; 86(2):930–4.
5. Raheem N, Ahmed SA, Samaila MO; Histopathological pattern of thyroid diseases in Zaria: a 10 year review; Niger Postgrad Med J, 2018; .25(1): 37-42.
6. Uloko AE, Nagoda M, Uloko AT, Reng R, Yusuf SM, Gezawa ID et al; Thyroid Disorders in Northern Nigeria - A Report of Clinical Patterns and Complications. Afr J of Endocrinol Metab (AJEM), 2015; 11(1):22-28.
7. Tamim H, Armenian H, Al Onazi M, Alshanafey S, Crisera V; in: Introduction to Clinical Research for Residents. J Health spec,2014;1-103.
8. Hou X, Li Y, Li J, Wang W, Fan C, Wang H,et al. Development of thyroid dysfunction and autoantibodies in
Graves' multiplex families. An eight-year follow-up study in Chinese Han pedigre. Thyroid, 2011; 21(12):1353-1358.
9. Lianzhe Hu, Guoba Xu. Application and Trends in Electrochemiluminescence. Chemical Society Review, R Soc Chemistry, 2010; 39:3275-3304.
10. Trinder Z, Determination of blood glucose using an oxidase peroxide system with a non-carcinogenic chromogen. J Clin Path. 1969; 22(2):158-161.
11. Strieder TGA, TijjsenJGP, Wenzel BE, Endert E, Wiersinga WM. Prediction of Progression to Overt Hypothyroidism or Hyperthyroidism in Female Relatives of Patients with Autoimmune Thyroid Disease Using the Thyroid Events Amsterdam (THEA) Score. Arch intern Med, 2008; 168(15):1657–1663.
12. Chopra IJ, Solomon DH, Chopra U, Yoshihara E, Terasalu PI, Smith F. Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto thyroiditis. J Clin EndocrinolMetab. 1977; 45:45-55.
13. Thomsen H, Li X, Sundquist C, Sundquist J, Forsti A, Hemminki K. Familial risks between Graves' disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden. J translational autoimmunity, 2020; 3:1-5.
14. Akamizu T, Nakamura Y, Tamaoki A, Inaba Y, Amino N, Seino Y. Prevalence and Clinico-Epidemiology of Familial Graves’ Disease in Japan based on Nationwide Epidemiologic Survey in 2001. Endocrine J, 2003;50(4):429–36.
15. Kanga U, Tandan N, Marwaha RK, Khanna R, Bhattacharya B, Singh S, et al in Immunogenic association and thyroid autoantibodies in juvenile autoimmune thyroiditis in North India. J Clin Endocrinol, 2006; 64:001-007.
16. Carey C, Skosey C, Pinnamaneni KM, Barsano CP, Degroot LJ. Thyroid abnormalities in children of parents who have Graves' disease. Metabolism, 1980; 29(4):369-376.
17. Desai MP, Karandikar S. Autoimmune thyroid disease in childhood: a study of children and their families. Indian paediatrics, 1999; 36:659-668.
18. Sobari AM, Rose NR, Brester HS, Vladut-Talor M, Burek LL.Iodination of human thyrogloblin alters its immunoreatiivity. Clin Exp immunology, 1998; 113:303-308.
19. Parveen K, Michael C. editors. The Thyroid gland in: Kumar and Clark’s Clinical Medicine. 9th ed. London: Elsevier; 2017; 26: 2287.
20. Devdhar M, Ousman YH, Burman KD. Hypothyroidism. Endocrinol Metab Clin North Am, 2007: 36(3):595-615.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.